• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质代谢相关长非编码 RNA RP11-817I4.1 促进肝癌中脂肪酸的合成和肿瘤进展。

Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.

机构信息

Second Affiliated Hospital of Kunming Medical University, Kunming 650106, Yunnan Province, China.

School of Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, Jiangsu Province, China.

出版信息

World J Gastroenterol. 2024 Feb 28;30(8):919-942. doi: 10.3748/wjg.v30.i8.919.

DOI:10.3748/wjg.v30.i8.919
PMID:38516243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10950635/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is one of the most common types of tumors. The influence of lipid metabolism disruption on the development of HCC has been demonstrated in published studies.

AIM

To establish an HCC prognostic model for lipid metabolism-related long non-coding RNAs (LMR-lncRNAs) and conduct in-depth research on the specific role of novel LMR-lncRNAs in HCC.

METHODS

Correlation and differential expression analyses of The Cancer Genome Atlas data were used to identify differentially expressed LMR-lncRNAs. Quantitative real-time polymerase chain reaction analysis was used to evaluate the expression of LMR-lncRNAs. Nile red staining was employed to observe intracellular lipid levels. The interaction between RP11-817I4.1, miR-3120-3p, and ATP citrate lyase (ACLY) was validated through the performance of dual-luciferase reporter gene and RIP assays.

RESULTS

Three LMR-lncRNAs (negative regulator of antiviral response, RNA transmembrane and coiled-coil domain family 1 antisense RNA 1, and RP11-817I4.1) were identified as predictive markers for HCC patients and were utilized in the construction of risk models. Additionally, proliferation, migration, and invasion were reduced by RP11-817I4.1 knockdown. An increase in lipid levels in HCC cells was significantly induced by RP11-817I4.1 through the miR-3120-3p/ACLY axis.

CONCLUSION

LMR-lncRNAs have the capacity to predict the clinical characteristics and prognoses of HCC patients, and the discovery of a novel LMR-lncRNAs, RP11-817I4.1, revealed its role in promoting lipid accumulation, thereby accelerating the onset and progression of HCC.

摘要

背景

肝细胞癌(HCC)是最常见的肿瘤类型之一。已发表的研究表明,脂质代谢紊乱对 HCC 的发展有影响。

目的

建立一个与脂质代谢相关的长链非编码 RNA(LMR-lncRNA)的 HCC 预后模型,并深入研究新型 LMR-lncRNA 在 HCC 中的具体作用。

方法

使用癌症基因组图谱数据的相关性和差异表达分析来鉴定差异表达的 LMR-lncRNA。采用实时定量聚合酶链反应分析评估 LMR-lncRNA 的表达。使用尼罗红染色观察细胞内脂质水平。通过双荧光素酶报告基因和 RIP 测定验证 RP11-817I4.1、miR-3120-3p 和三磷酸腺苷柠檬酸裂解酶(ACLY)之间的相互作用。

结果

三种 LMR-lncRNA(抗病毒反应负调控因子、RNA 跨膜和卷曲螺旋域家族 1 反义 RNA 1 和 RP11-817I4.1)被鉴定为 HCC 患者的预测标志物,并用于构建风险模型。此外,RP11-817I4.1 敲低可降低 HCC 细胞的增殖、迁移和侵袭能力。RP11-817I4.1 通过 miR-3120-3p/ACLY 轴显著诱导 HCC 细胞内脂质水平升高。

结论

LMR-lncRNA 能够预测 HCC 患者的临床特征和预后,新型 LMR-lncRNA RP11-817I4.1 的发现揭示了其促进脂质积累的作用,从而加速 HCC 的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/1f7e686c2be0/WJG-30-919-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/ece69b1deee2/WJG-30-919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/53e2ffa6cdfa/WJG-30-919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/0ed18e9ae0c0/WJG-30-919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/49eb82b7664e/WJG-30-919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/6594c2eac665/WJG-30-919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/f38ca968e87a/WJG-30-919-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/2bfc4d4fde9d/WJG-30-919-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/1f7e686c2be0/WJG-30-919-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/ece69b1deee2/WJG-30-919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/53e2ffa6cdfa/WJG-30-919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/0ed18e9ae0c0/WJG-30-919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/49eb82b7664e/WJG-30-919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/6594c2eac665/WJG-30-919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/f38ca968e87a/WJG-30-919-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/2bfc4d4fde9d/WJG-30-919-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa3/10950635/1f7e686c2be0/WJG-30-919-g008.jpg

相似文献

1
Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.脂质代谢相关长非编码 RNA RP11-817I4.1 促进肝癌中脂肪酸的合成和肿瘤进展。
World J Gastroenterol. 2024 Feb 28;30(8):919-942. doi: 10.3748/wjg.v30.i8.919.
2
A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.一种新型长链非编码 RNA RP11-386G11.10 重编程脂质代谢促进肝癌进展。
Mol Metab. 2022 Sep;63:101540. doi: 10.1016/j.molmet.2022.101540. Epub 2022 Jul 5.
3
RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.RP11-295G20.2 通过 miR-6884-3p/CCNB1 通路促进肝细胞癌进展。
Aging (Albany NY). 2020 Jul 20;12(14):14918-14932. doi: 10.18632/aging.103552.
4
A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.一种新型长非编码 RNA RP11-286H15.1 通过促进 PABPC4 的泛素化来抑制肝癌进展。
Cancer Lett. 2021 Feb 28;499:109-121. doi: 10.1016/j.canlet.2020.11.038. Epub 2020 Nov 28.
5
Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.长链非编码 RNA HOTAIR 通过调控 miR-526b-3p/DHX33 轴促进肝癌进展。
Genes Genomics. 2021 Aug;43(8):857-868. doi: 10.1007/s13258-021-01098-9. Epub 2021 Apr 12.
6
Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.长链非编码 RNA UPK1A-AS1 提示肝细胞癌预后不良,并通过与 EZH2 相互作用促进细胞增殖。
J Exp Clin Cancer Res. 2020 Oct 29;39(1):229. doi: 10.1186/s13046-020-01748-y.
7
Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma.脂质代谢相关长非编码 RNA:肝细胞癌潜在的预后生物标志物。
World J Gastroenterol. 2024 Sep 7;30(33):3799-3802. doi: 10.3748/wjg.v30.i33.3799.
8
RP11-81H3.2 Acts as an Oncogene via microRNA-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma.RP11-81H3.2 通过抑制 microRNA-490-3p 和上调 Tankyrase 2 促进肝癌的发生。
Dig Dis Sci. 2020 Oct;65(10):2949-2958. doi: 10.1007/s10620-019-06007-5. Epub 2019 Dec 19.
9
HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.HOXA-AS2通过miR-520c-3p/GPC3轴促进肝癌细胞增殖并诱导上皮-间质转化
Cell Physiol Biochem. 2018;50(6):2124-2138. doi: 10.1159/000495056. Epub 2018 Nov 9.
10
Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.长链非编码 RNA 母系表达基因 3 通过靶向 microRNA-5195-3p 并调节叉头框 O1 的表达来抑制肝细胞癌的进展。
Bioengineered. 2021 Dec;12(2):12880-12890. doi: 10.1080/21655979.2021.2005986.

引用本文的文献

1
Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy.4-甲基伞形酮对雄黄-黄连中FAS和HAS2/3的双重抑制揭示了肝癌治疗的代谢检查点。
Nat Prod Bioprospect. 2025 Aug 21;15(1):56. doi: 10.1007/s13659-025-00540-9.
2
Lipid metabolism-related long noncoding RNAs: A potential prognostic biomarker for hepatocellular carcinoma.脂质代谢相关长非编码 RNA:肝细胞癌潜在的预后生物标志物。
World J Gastroenterol. 2024 Sep 7;30(33):3799-3802. doi: 10.3748/wjg.v30.i33.3799.
3
Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects.

本文引用的文献

1
Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma.二硫键相关长非编码 RNA 特征可评估肝癌的免疫微环境和药物敏感性。
Comput Biol Med. 2024 Feb;169:107930. doi: 10.1016/j.compbiomed.2024.107930. Epub 2024 Jan 4.
2
LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin.长链非编码RNA TGFB2-OT1通过使β-连环蛋白去磷酸化促进肝细胞癌的进展和血管生成。
J Hepatocell Carcinoma. 2023 Mar 14;10:429-446. doi: 10.2147/JHC.S404008. eCollection 2023.
3
METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
外泌体长链非编码RNA在肝脏疾病中的动态作用:发病机制与诊断方面
Hepatol Int. 2024 Dec;18(6):1715-1730. doi: 10.1007/s12072-024-10722-1. Epub 2024 Sep 21.
METTL5 通过促进 USP5 翻译来稳定 c-Myc,从而重新编程葡萄糖代谢并促进肝细胞癌的进展。
Cancer Commun (Lond). 2023 Mar;43(3):338-364. doi: 10.1002/cac2.12403. Epub 2023 Jan 5.
4
A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma.一个六脂质代谢相关基因特征预测肝细胞癌的预后。
Sci Rep. 2022 Dec 1;12(1):20781. doi: 10.1038/s41598-022-25356-2.
5
Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma.脂质代谢相关长链非编码RNA的预后特征预测肺腺癌的预后和治疗
Front Oncol. 2022 Nov 1;12:986367. doi: 10.3389/fonc.2022.986367. eCollection 2022.
6
Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer.脂质代谢相关长链非编码 RNA 标志物在结直肠癌风险分层和免疫微环境中的作用。
BMC Med Genomics. 2022 Oct 21;15(1):221. doi: 10.1186/s12920-022-01369-8.
7
Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling.长链非编码 RNA 在脂质代谢和信号转导中的最新进展及未来展望。
J Adv Res. 2023 Jun;48:105-123. doi: 10.1016/j.jare.2022.08.007. Epub 2022 Aug 13.
8
Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma.鉴定脂肪酸代谢相关长链非编码 RNA 对结肠腺癌预后及免疫微环境的影响。
Biol Direct. 2022 Jul 28;17(1):19. doi: 10.1186/s13062-022-00332-y.
9
A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.一种新型长链非编码 RNA RP11-386G11.10 重编程脂质代谢促进肝癌进展。
Mol Metab. 2022 Sep;63:101540. doi: 10.1016/j.molmet.2022.101540. Epub 2022 Jul 5.
10
Long non-coding RNA NRAV enhances proliferation and invasion of hepatocellular carcinoma cells by modulating the Wnt/β-catenin signaling pathway.长非编码 RNA NRAV 通过调节 Wnt/β-catenin 信号通路增强肝癌细胞的增殖和侵袭。
Bioengineered. 2022 Apr;13(4):10026-10037. doi: 10.1080/21655979.2022.2062977.